Case-Based Roundtable
General Dermatology
Eczema
Chronic Hand Eczema
Alopecia
Aesthetics
Vitiligo
COVID-19
Actinic Keratosis
Precision Medicine and Biologics
Rare Disease
Wound Care
Rosacea
Psoriasis
Psoriatic Arthritis
Atopic Dermatitis
Melasma
NP and PA
Skin Cancer
Hidradenitis Suppurativa
Drug Watch
Pigmentary Disorders
Acne
Pediatric Dermatology
Practice Management
Prurigo Nodularis
Buy-and-Bill

Strategies for Managing Alopecia Areata : Episode 1

Opinion

Video

March 4, 2025

Alopecia Areata Clinical Presentation and Challenges in Treatment

Author(s):

An expert discusses how alopecia areata affects approximately 2% of the population globally, with onset typically in childhood or early adulthood. Patients often present with autoimmune comorbidities (thyroid disorders, vitiligo, atopic dermatitis) and psychological distress. Diagnostic challenges include differentiating from other hair loss conditions and predicting disease course. Treatment difficulties involve unpredictable responses, lack of standardized protocols, and addressing both physical symptoms and psychological impact.

Now Viewing

EP: 1.Alopecia Areata Clinical Presentation and Challenges in Treatment

EP: 2.Defining Alopecia Areata Severity and Navigating Treatment Options

Video content above is prompted by the following:

Discuss the prevalence of alopecia areata. What are some patient characteristics or comorbidities often seen in patients with alopecia areata?
What are some of the challenges of diagnosing and treating alopecia areata?